Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.

Xanomeline is a unique agonist of muscarinic receptors that possesses functional selectivity at the M(1) and M(4) receptor subtypes. It also exhibits wash-resistant binding to and activation of the receptor. In the present work we investigated the consequences of this type of binding of xanomeline o...

Full description

Bibliographic Details
Main Authors: Marianne K O Grant, Meredith J Noetzel, Kayla C De Lorme, Jan Jakubík, Vladimír Doležal, Esam E El-Fakahany
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-12-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3009740?pdf=render
id doaj-fd8b3d721fb04aa3801c4db01a89e428
record_format Article
spelling doaj-fd8b3d721fb04aa3801c4db01a89e4282020-11-25T01:52:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-12-01512e1572210.1371/journal.pone.0015722Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.Marianne K O GrantMeredith J NoetzelKayla C De LormeJan JakubíkVladimír DoležalEsam E El-FakahanyXanomeline is a unique agonist of muscarinic receptors that possesses functional selectivity at the M(1) and M(4) receptor subtypes. It also exhibits wash-resistant binding to and activation of the receptor. In the present work we investigated the consequences of this type of binding of xanomeline on the binding characteristics and function of the M(1) muscarinic receptor. Pretreatment of CHO cells that stably express the M(1) receptor for 1 hr with increasing concentrations of xanomeline followed by washing and waiting for an additional 23 hr in control culture media transformed xanomeline-induced inhibition of [(3)H]NMS binding from monophasic to biphasic. The high-affinity xanomeline binding site exhibited three orders of magnitude higher affinity than in the case of xanomeline added directly to the binding assay medium containing control cells. These effects were associated with a marked decrease in maximal radioligand binding and attenuation of agonist-induced increase in PI hydrolysis and were qualitatively similar to those caused by continuous incubation of cells with xanomeline for 24 hr. Attenuation of agonist-induced PI hydrolysis by persistently-bound xanomeline developed with a time course that parallels the return of receptor activation by prebound xanomeline towards basal levels. Additional data indicated that blockade of the receptor orthosteric site or the use of a non-functional receptor mutant reversed the long-term effects of xanomeline, but not its persistent binding at an allosteric site. Furthermore, the long-term effects of xanomeline on the receptor are mainly due to receptor down-regulation rather than internalization.http://europepmc.org/articles/PMC3009740?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Marianne K O Grant
Meredith J Noetzel
Kayla C De Lorme
Jan Jakubík
Vladimír Doležal
Esam E El-Fakahany
spellingShingle Marianne K O Grant
Meredith J Noetzel
Kayla C De Lorme
Jan Jakubík
Vladimír Doležal
Esam E El-Fakahany
Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
PLoS ONE
author_facet Marianne K O Grant
Meredith J Noetzel
Kayla C De Lorme
Jan Jakubík
Vladimír Doležal
Esam E El-Fakahany
author_sort Marianne K O Grant
title Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
title_short Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
title_full Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
title_fullStr Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
title_full_unstemmed Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
title_sort pharmacological evaluation of the long-term effects of xanomeline on the m(1) muscarinic acetylcholine receptor.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2010-12-01
description Xanomeline is a unique agonist of muscarinic receptors that possesses functional selectivity at the M(1) and M(4) receptor subtypes. It also exhibits wash-resistant binding to and activation of the receptor. In the present work we investigated the consequences of this type of binding of xanomeline on the binding characteristics and function of the M(1) muscarinic receptor. Pretreatment of CHO cells that stably express the M(1) receptor for 1 hr with increasing concentrations of xanomeline followed by washing and waiting for an additional 23 hr in control culture media transformed xanomeline-induced inhibition of [(3)H]NMS binding from monophasic to biphasic. The high-affinity xanomeline binding site exhibited three orders of magnitude higher affinity than in the case of xanomeline added directly to the binding assay medium containing control cells. These effects were associated with a marked decrease in maximal radioligand binding and attenuation of agonist-induced increase in PI hydrolysis and were qualitatively similar to those caused by continuous incubation of cells with xanomeline for 24 hr. Attenuation of agonist-induced PI hydrolysis by persistently-bound xanomeline developed with a time course that parallels the return of receptor activation by prebound xanomeline towards basal levels. Additional data indicated that blockade of the receptor orthosteric site or the use of a non-functional receptor mutant reversed the long-term effects of xanomeline, but not its persistent binding at an allosteric site. Furthermore, the long-term effects of xanomeline on the receptor are mainly due to receptor down-regulation rather than internalization.
url http://europepmc.org/articles/PMC3009740?pdf=render
work_keys_str_mv AT mariannekogrant pharmacologicalevaluationofthelongtermeffectsofxanomelineonthem1muscarinicacetylcholinereceptor
AT meredithjnoetzel pharmacologicalevaluationofthelongtermeffectsofxanomelineonthem1muscarinicacetylcholinereceptor
AT kaylacdelorme pharmacologicalevaluationofthelongtermeffectsofxanomelineonthem1muscarinicacetylcholinereceptor
AT janjakubik pharmacologicalevaluationofthelongtermeffectsofxanomelineonthem1muscarinicacetylcholinereceptor
AT vladimirdolezal pharmacologicalevaluationofthelongtermeffectsofxanomelineonthem1muscarinicacetylcholinereceptor
AT esameelfakahany pharmacologicalevaluationofthelongtermeffectsofxanomelineonthem1muscarinicacetylcholinereceptor
_version_ 1724994016109395968